Jan 19,2023

Top Artificial Intelligence Companies In Healthcare To Keep An Eye On

The medical AI industry is rapidly evolving, with an increasing number of companies seeking to revolutionize healthcare using artificial intelligence. It can be difficult to keep track of the most promising ones due to the rapid turnover of such companies. However, there are several significant players in the field, ranging from startups to tech giants, that should be closely monitored for their potential impact on healthcare. Among the companies to watch are Behold.ai, Oxipit, and Turbine, which all have a focus on Oncology.

#ai/software

#rwd

View Analyst & Ambassador Comments
Go to original news
Jan 24,2023

How Real-World Data Helps Explore Alternative Dosing for Colorectal, Pancreatic Cancer Therapy

A joint effort between MedStar Georgetown Lombardi Comprehensive Cancer Center and COTA has demonstrated the feasibility of a patient-oriented dosing schedule for Stage 4 CRC/PC or locally advanced PC. This partnership showcases the contribution of real-world data to clinical research, which can provide insights into care that is currently being administered in clinical settings and help address critical questions.

CLINICAL STUDY

#rwd

#rwe

View Analyst & Ambassador Comments
Go to original news
Jan 25,2023

What Makes a Fit-for-Purpose Database for Clinical Oncology Research?

A fit-for-purpose database includes key variables, reliable and accurate data, and representative samples that can be used to draw meaningful conclusions. lthough Real-World Data (RWD) can be extremely beneficial in supporting clinical oncology research, selecting the appropriate data is crucial. The keys to finding the right fit-for-purpose database include relevance, reliability, integrity, and bias.

#rwd

View Analyst & Ambassador Comments
Go to original news
Jan 30,2023

NHS trials AI technology offering same-day diagnosis of aggressive lung cancer which kills 35,000 Britons each year

The software, developed by Indian tech company Qure.ai is being rolled out across Greater Manchester as part of a pilot study being led by AstraZeneca involving more than 250,000 people over the next six months. The program analyses X-ray scans immediately after they are carried out and alerts doctors if any worrying signs are spotted. Doctors reviewing x-rays for possible signs of lung cancer can take up to a week to provide a diagnosis, which can harm the patient's long-term prospects .

COLLABORATION PARTNERSHIP

#data & technology

#ai/software

#rwd

View Analyst & Ambassador Comments
Go to original news
Jan 31,2023

COTA, Inc. Forms Strategic Real-World Data Research Partnership with the Clinical Research Data Sharing Alliance

COTA, Inc., a company specializing in oncology real-world data and analytics, has become a member of the Clinical Research Data Sharing Alliance (CRDSA). This is a non-profit alliance that includes biopharmaceutical companies, data sharing platforms, academic institutions, and service and technology partners, working together to expedite the discovery and provision of life-saving treatments to patients by leveraging high-quality clinical trials and real-world data.

#rwd

View Analyst & Ambassador Comments
Go to original news
Feb 02,2023

Sleep Number Honored with American Cancer Society’s 2022 Corporate Partner of the Year Award

In advance of World Cancer Day on February 4, Sleep Number Corporation (Nasdaq: SNBR) today announces it is the proud recipient of the American Cancer Society’s (ACS) 2022 Corporate Partner of the Year Award. Over the next five years, ACS will leverage Sleep Number’s proprietary sleep data and sleep expertise in its research to identify the impact of quality sleep on cancer prevention and recovery.

#rwd

View Analyst & Ambassador Comments
Go to original news
Nov 14,2022

API Platform to Enable Jasper Health to Generate More Advanced Patient Insights and Elevate Customized Cancer Care

Announced today, Jasper Health and Particle Health, an integrations and API platform that has modernized the health data experience for healthcare companies, have partnered to generate enhanced health data insights to augment personalized cancer care support. Access to actionable shared health data allows clinicians and Jasper care coaches to identify barriers to healthcare and provide curated health insights relevant to members and their specific health needs. Particle Health’s API complements Jasper Health’s existing clinical data integrations to leverage meaningful health data to improve cancer care support and delivery, and elevate members’ experience, quality of life, and outcomes.

COLLABORATION PARTNERSHIP

#data & technology

#rwd

#coaching

View Analyst & Ambassador Comments
Go to original news
Nov 14,2022

COTA and Google Partner to Use Natural Language Processing to Harness Unstructured Data

Finding a way to consistently and accurately extract unstructured data is one of the top goals for technologists, including a newly formed team of machine learning experts at COTA, Google, John Snow Labs, and Quantiphi. Together, the partners are using breakthroughs in machine learning and natural language processing (NLP) to extract unstructured data elements from EHRs to fuel innovation in oncology research and treatment.

COLLABORATION PARTNERSHIP

#data & technology

#ml

#rwd

View Analyst & Ambassador Comments
Go to original news
Nov 28,2022

Lunit Unveils Real-World Data Backing Clinical Efficacy of AI for the First Time in Breast Cancer Research; Abstracts to be Presented at RSNA 2022

Lunit, a global provider of AI-powered cancer solutions, today announced that it unveiled real-world data (RWD) validating the clinical efficacy of AI in actual medical settings for the first time in the field of breast cancer research at this year's RSNA meeting. The company will be presenting a total of 12 abstracts—8 oral presentations and 4 poster presentations—at the 108th RSNA Annual Meeting to be held from Nov. 27 – Dec. 1.

CONFERENCES

#rwd

#ai/software

View Analyst & Ambassador Comments
Go to original news
Dec 01,2022

The Power of Collaboration: ASH Showcases COTA’s Real World Data and Research at Annual Meeting

COTA is honored to announce that our team has directly contributed to three abstracts accepted for poster presentation at the December conference. Two of these studies were conducted in close partnership with researchers from the FDA. Four other accepted abstracts leverage COTA’s real-world data (RWD) to support their crucial work around hematologic cancer.

CLINICAL STUDY

#rwd

View Analyst & Ambassador Comments
Go to original news
Subscribe to RWD